Description
A positive allosteric modulator of adenosine A3 receptors; reduces dissociation of I-AB-MECA from A3 receptors and increases the efficacy, but not potency, of 2-Cl-IB-MECA-induced inhibition of forskolin-stimulated cAMP accumulation by 45% in CHO cells expressing the human receptor at 10 μM; reduces joint edema and decreases levels of PI3K, IKK, IκB, and NF-κB in PBMCs in a rat model of adjuvant-induced arthritis at 100 μg/kg, three times per day; reduces knee edema in a rat model of MIA-induced osteoarthritis at 100 μg/kg twice per day
Formal name: 2-cyclohexyl-N-(3,4-dichlorophenyl)-3H-imidazo[4,5-c]quinolin-4-amine
Synonyms:
Molecular weight: 411.3
CAS: 890087-21-5
Purity: ≥98%
Formulation: A solid